Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Aetna Inc. (AET - Analyst Report) reported second-quarter 2013 earnings of $1.52 per share, up 13 cents per share from the Zacks Consensus Estimate of $1.39 per share. Earnings also increased 16% year over year.
 
Including one time items net income came in at $1.49 per share, up 13% year over year.
 
Aetna’s total revenue for the reported quarter grew 31% year over year to $11.5 billion, led by higher Health Care premiums in Commercial, Medicare and Medicaid businesses. Reported revenue was a tad lower than the Zacks Consensus Estimate of $11.8 billion.
 
Operating expenses were $2.04 billion, up 27.4% year over year. Operating expense ratio was 17.7% compared with 18.7% in the prior-year quarter.
 
Pre-tax operating margin was 8.4% for the reported quarter, down 50 basis points year over year.
 
Segmental Performance
 
Aetna’s Health Care segment recorded revenues of $10.87 billion, up 33% year over year.
 
Total medical membership was 21.968 million as of Jun 30, 2013. This signifies a yearly increase of 3.939 million members.
 
Operating earnings increased by 26% year over year to $559.2 million, largely attributable to higher underwriting margins in its Commercial business.
 
Aetna’s Group Insurance revenues climbed 11% year over year to $582.4 million. The segment’s operating earnings decreased by 35% year over year to $29.9 million reflecting lower underwriting margin in Life business.
 
At Large Case Pensions, revenues slipped 0.7% year over year to $106.3 million. Operating earnings increased by 2.6% year over year to $3.8 million.
 
In the reported quarter, Aetna spent $440.6 million to buyback 7.2  million shares.
 
2013 Guidance
 
Following a better-than-expected earnings performance, Aetna raised its full year 2013 earnings guidance to a range of $5.80 to $5.90, from its earlier forecast of $5.50 to $5.60.
 
Aetna currently retains a Zacks Rank #2 (Buy). Other players UnitedHealth Group Inc. (UNH - Analyst Report), WellPoint Inc. (WLP - Analyst Report), Molina Healthcare Inc. (MOH - Analyst Report) all reported second quarter earnings ahead of the Zacks Consensus Estimates.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%